Cisplatin with high-dose infusions of hydroxyurea to inhibit DNA repair. A phase II study in non-small-cell lung cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/2538251

Download in:

View as

General Info

PMID
2538251